Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma
about
Stem cells as cellular vehicles for gene therapy against glioblastomaTargeting Mcl-1 for the therapy of cancerDeveloping an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicAdenoviral vector-mediated gene therapy for gliomas: coming of age.The development of MDA-7/IL-24 as a cancer therapeuticCurrent status of gene therapy for brain tumors.A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapyEnhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene deliveryA serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approachApogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Gene Therapies for Cancer: Strategies, Challenges and Successes.mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cellsSuppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceHistone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cellsOptimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?Inhibitory effect of melanoma differentiation associated gene-7/interleukin-24 on invasion in vitro of human melanoma cancer cells.Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.Enhancing CHK1 inhibitor lethality in glioblastoma.The potential of virus-based gene therapies for treatment of metastatic kidney cancer.Cancer Terminator Viruses (CTV): A Better Solution for Viral-Based Therapy of Cancer.Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.
P2860
Q26771835-0FA350CA-4F32-4CA2-8B92-3D8BB37FD338Q27011870-94B92D30-5370-4A56-8CEE-F2793847B52CQ27694606-8A8A006B-5643-4E39-B4ED-C86F4E7DD3B4Q34022048-C1B187CF-08EE-46F4-B1F8-A279A0367A05Q34163896-BE68EC50-6E8D-4AA5-A8DA-8E1DE209AF34Q34318157-93C89244-8886-4258-A31C-753C10013570Q34341900-DB78D5EB-E58D-4974-B8D7-A8199B2CE69DQ34616542-AD0DA4E9-8618-40B8-A1F6-005F558D4C1EQ34701049-7B094858-E436-4E89-B961-685DC1435B46Q34946787-57946E3E-D711-417B-8B09-BE43F3C939CDQ35008409-379D7E37-661B-4F94-A292-B3003F4A0011Q35095082-908DC2F1-B783-4D96-9912-9AC47334F714Q35142325-79A654FF-A2FF-4D90-831D-109DF9272B57Q35186312-BFF190F8-12DD-469F-90F0-5CB54E9C1929Q35189796-DDF4D1C2-715A-40C6-9104-D2C8EED82CB7Q35587169-DDF351D6-2328-4334-92A0-D8019933ABDFQ36545638-4486C312-9E70-43DB-99BF-8BB7ACC0D3A3Q37027060-D133DAD2-859C-41F1-8AA4-D0A12A30252EQ37586906-976D7545-1E86-4F76-80A7-A06D2AB065C2Q38025696-DD986340-2A43-4321-957C-B7EF34758F3CQ39136061-4EB6260A-BE3E-4186-9959-D80CD37E293FQ39138800-A2F8AEFD-C3F0-4904-A48A-48EB125F52D8Q40253067-DACF52E5-9629-4545-96DC-99CA40B0F97AQ41767263-68EEC046-2879-4691-ACA1-3B090E319B7CQ45365447-BF7151BE-32E1-4AEE-AF3F-E9C1A672E8EAQ47560447-37CB3EDF-5A89-4398-93E0-4035DAF5EAD6Q54195846-86B42124-CAC7-4816-9D87-B34F8D4EF03E
P2860
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@ast
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@en
type
label
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@ast
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@en
prefLabel
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@ast
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@en
P2093
P2860
P50
P356
P1433
P1476
Inhibition of multiple protect ...... 24 therapy of malignant glioma
@en
P2093
Adly Yacoub
Devanand Sarkar
Hossein A Hamed
Igor P Dmitriev
Khalid Shah
Maciej S Lesniak
Margaret A Park
Patrick J Eulitt
Paul B Fisher
Steven Grant
P2860
P304
P356
10.1038/MT.2010.29
P577
2010-02-23T00:00:00Z